BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Stratophase Ltd to Exhibit at BioTechnica 2011


9/29/2011 10:10:27 AM

Romsey, UK – 29 September 2011– Stratophase, innovators in real-time in situ monitoring and diagnostics, will be exhibiting and showcasing its unique SpectroSens™ optical microchip technology at Biotechnica 2011 (11th – 13th October). SpectroSens draws on Stratophase’s expertise in fibre optic communications and solid state silicon device manufacture to create a powerful sensing tool for real-time, in-line monitoring and portable biological detection. The applications of this technology are diverse, including the optimisation of bioreactor processes such as those used in the biopharmaceutical manufacturing industry, as well as disease diagnosis by combining SpectroSens chips with highly specific immunoassay chemistry.

Stratophase has recently partnered with several well-known organisations such as the UK Ministry of Defence and a consortium consisting of GlaxoSmithKline, Green Biologics and the Centre for Process Innovation (CPI) to test and validate SpectroSens in a diverse range of environments. These projects have identified that SpectroSens can provide a real-time, in-line liquid monitoring system to both improve the efficiency of production processes and provide rapid, on-site biodetection.

By using light to measure change, Stratophase’s unique technology brings precision, flexibility and cost effectiveness to real-time monitoring and diagnostics. When used for bioreactor monitoring, the transfer of information via fibre optics provides speed and high signal fidelity. This approach also means that multiple sensors can be easily networked together, generating results from multiple bioreactors accessible via a single control unit situated up to hundreds of metres away if necessary. When employed in a biodetection environment, one disposable chip can be used to test multiple samples simultaneously, or several biological targets within a single sample. Such a range of features allow SpectroSens chips to provide a wealth of benefits, whatever the chosen application.

To find out more, visit Stratophase’s Biotechnica Stand A28, Hall 9, or see the website at www.stratophase.com

About Stratophase:

Stratophase is a VC-funded spin-out from the University of Southampton in the UK. Its unique technology is an optical microchip sensor which measures chemical processes and detects biological targets. This core optical measurement technology can be realised in a vast array of sensing heads, offering a wide variety of system configurations applicable to a broad spectrum of industries including biochemical production as well as biological detection.

The Stratophase team includes the original inventors of the SpectroSens technology as well as senior managers with a vast array of industry experience.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->